You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》健倍苗苗(02161.HK)明日起招股 入場費2,424.18元
阿思達克 01-25 17:13
由雅各臣(02633.HK)分拆的從事品牌醫療保健公司健倍苗苗(02161.HK)公布招股詳情,計劃發售4,468.6萬股股份,招股價為1.2元,每手2,000股,入場費為2,424.18元。由明日(26日)至本周五(29日)中午公開招股,預計於2月5日上市。中國銀河國際證券(香港)為獨家保薦人。

公司預計所得款項淨額估計約為1,060萬元,當中47.2%將用於為品牌中藥的組合開發及品牌管理提供資金;43.4%將用於作為發展第三方品牌產品組合增長策略的一部分,為從第三方品牌擁有人獲得更多分銷權的付款提供資金;9.4%為補充營運資金及用於一般企業用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account